AI reads CT scans to spot pancreatic cancer and prevent needless surgery
NCT ID NCT07439757
First seen Mar 14, 2026 · Last updated Apr 29, 2026 · Updated 2 times
Summary
This study tests an artificial intelligence (AI) system that helps doctors diagnose pancreatic diseases using contrast-enhanced CT scans. The AI compares its recommendations with those of experienced doctors to see if it can accurately classify patients into treatment, close monitoring, or routine follow-up. The goal is to catch dangerous tumors early and avoid unnecessary surgeries. About 2,000 adults with suspected pancreatic disease will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Changhai Hospital
RECRUITINGShanghai, 200433, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.